Gaia Science Pte Ltd’s Post

🔬 Molecular chemist Alice Ting and her team at Stanford University have devised a new tagging system that enables scientists to track protein traffic in living cells. This new method, dubbed "TransitID," was detailed in a paper published in Cell Press in 2023. 🇹🇼 Born in Taiwan, Ting received The Vilcek Foundation Prize for Creative Promise in Biomedical Science in 2012 for the development of sophisticated tools for the detection and visualization of individual biomolecules. 🔗 Read more on Ting's research and the potential for TransitID in the following article from Stanford University. #BiomedicalResearch #BiomedicalScience #DiversityinScience #DiversityinSTEM #Stanford #StanfordUniversity #WomeninScience #WomeninSTEM

ARTICLE | Our research on a 𝗺𝗶𝗰𝗿𝗼𝗳𝗹𝘂𝗶𝗱𝗶𝗰 𝗱𝗲𝘃𝗶𝗰𝗲 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗮𝘂𝘁𝗼𝗺𝗮𝘁𝗲𝗱 𝗴𝗿𝗼𝘄𝘁𝗵 𝗮𝗻𝗱 𝗱𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝘁𝗶𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗰𝗲𝗿𝗲𝗯𝗿𝗮𝗹 𝗼𝗿𝗴𝗮𝗻𝗼𝗶𝗱𝘀 𝗳𝗿𝗼𝗺 𝘀𝗶𝗻𝗴𝗹𝗲-𝗰𝗲𝗹𝗹 𝘀𝘂𝘀𝗽𝗲𝗻𝘀𝗶𝗼𝗻𝘀 has been published in the 𝗕𝗶𝗼𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 𝗝𝗼𝘂𝗿𝗻𝗮𝗹! 👉 Our team leader, Zbynek Prokop, and alumnus Tomas Landolt (Buryska) collaborated with researchers from Faculty of Medicine, Masaryk University, St. Anne's University Hospital Brno, CEITEC - Central European Institute of Technology and Institute of Molecular Genetics of the Czech Academy of Sciences on the development of a microfluidic chip aimed at simplifying and enhancing the formation and differentiation of cerebral organoids - a unique platform for investigating neural diseases. 👉 Our findings emphasize how custom-designed microfluidic technology can increase culture medium efficiency while minimizing maintenance time. 👉 Check it out: https://lnkd.in/g-uBZ4tX #research #biomedicine #biochemistry #biotechnology #nicrofluidics #neuraldisease #technology 

Introducing The Lab for Molecular Biology of Aging, led by Dr. Bar Daniel Zvi. The lab addresses the critical need to understand and treat the aging process, as it remains the primary risk factor for many diseases. Employing innovative methods, such as novel protein environment analysis and proximity-labeling techniques, the lab investigates age-related changes in subcellular structures and DNA-protein interactions. By comprehensively exploring these mechanisms, the lab aims to contribute to the modulation of aging and ultimately improve healthspan and lifespan. To learn more about this lab, its capabilities and potential applications, please contact Tali Aloya, Ph.D., VP of Business Development in Life Sciences at Ramot: tali.aloya@Ramot.org #aging #biology #lab #innovation #research #researchinnovation #longevity

✨ Partner Spotlight: Universidad Complutense de Madrid (UCM) ✨ We are proud to shine the spotlight on Universidad Complutense de Madrid, a crucial partner in our ISOS Project EU, funded by the prestigious #EICPathfinder! 📍 As one of the most renowned universities in Europe, UCM brings world-class research and expertise to the forefront of our project. UCM leads Work Package 1 (WP1), focusing on in-silico studies and the design of genetically engineered bacteria (GEB) ecosystems in the ISOS Engineered Living Material (ELM). Their team is pioneering innovations in #biomaterials, #ELMs, #microbiology and advanced personalized therapies, playing a pivotal role in developing the groundbreaking technologies for in-situ fabrication and auto-renewed delivery of therapeutic compounds. 🔹 Together with UCM and our consortium partners, we’re revolutionizing chronic disease treatment and driving advancements in personalized medicine and biomedical research. #GeneticEngineering #Microbiology #PersonalizedMedicine #InnovationInHealth #RegenerativeMedicine #ISOSProjectEU #ChronicDiseaseTreatment #EICPathfinder #EUResearch

Very interesting read on the rise of automation in proteomics. Check it out below!

Very interesting read on the rise of automation in proteomics. Check it out below!

👋🏽 Meet Marc Talló Parra, our principal researcher and co-founder. 👨🏽🔬 Marc holds a degree in Human Biology, a master’s degree in Biomedical Research, and a PhD in Biomedicine from Universitat Pompeu Fabra. 🧬 He is the coinventor of the patent that led to NoctuRNA's circRNA technology. He specialized in molecular virology and RNA biology and conducted his doctoral research on the interaction between viruses and circRNAs, exploring the translational implications of these molecules. 🏆 In 2019, he was awarded the Tech Transfer Prize from UPF, and in the same year, he received the Extraordinary Award for Best Doctoral Thesis from UPF. He has published four scientific articles in high-impact journals. 💬 In Marc's own words:  "It is exciting to see how a project that started as an innovative, crazy idea in the lab goes beyond basic research and can reach the market. With this project, I fulfilled the dream of translating our research into a therapeutic application." We are building the best team to lead the circRNA therapeutic revolution! #therapeutics #circRNA #noctuRNA #biotech

Very interesting read on the rise of automation in proteomics. Check it out below!

🌟 Insights from the 2021 IEEE BIBM 3rd Annual LncRNA Workshop! 🌟 I had the opportunity to participate in the 2021 IEEE BIBM 3rd Annual LncRNA Workshop in Dubai, UAE. Our viewpoint captures critical discussions on a novel recently published: Challenges in Computational Analysis of lncRNAs lncRNAs and Cancer lncRNAs in Sports lncRNAs and COVID-19 lncRNAs in Human Brain Activity See in details here: https://lnkd.in/eARGmNBm Thanks to IEEE and BIBM for this event and to all contributors. Let’s continue to innovate and apply these insights to advance bioinformatics outcomes. #lncRNA #Bioinformatics #IEEEBIBM #AI

A very timely article in Genetic Engineering and Biotechnology News from Opentrons’ own James Atwood and our friend Joao Paulo at Harvard Medical School on the rise of automation in proteomics! The article underscores the dominant role of mass spectrometry in advancing proteomic research, highlighting how recent technological advancements have continued to eclipse improvements in other approaches. From single-cell analysis to unbiased discovery proteomics, mass spectrometry researchers now have unprecedented tools at their disposal to study thousands of proteins with remarkable speed and efficiency. One key takeaway is the importance of automation in overcoming the upstream bottleneck of sample preparation—a challenge that Dr. Paulo overcame using his Opentrons robot. Our newly launched Flex robot offers a cutting-edge solution for streamlining sample processing, enabling sample preparation to keep pace with proteomic analysis. The article also features success stories from institutions like Universitätsmedizin Greifswald and the Københavns Universitet - University of Copenhagen, where Opentrons robots have played a pivotal role in accelerating proteomic research. From reducing hands-on time to enabling complete automation of sample preparation, our technology is driving innovation and efficiency across the proteomics landscape. As we look ahead, the integration of automation into proteomics promises to unlock even greater possibilities, empowering scientists to delve deeper into the proteome and revolutionize our understanding of disease. At Opentrons, we're committed to advancing the frontiers of laboratory automation, empowering researchers to focus on what matters most—scientific breakthroughs. Read the article in GEN: https://bit.ly/3Wlw6tN Links to more proteomics automation resources in the comments! #Proteomics #LabAutomation #Innovation #Opentrons #FlexRobot #MassSpectrometry